Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas.
J Neurooncol
; 145(1): 57-63, 2019 Oct.
Article
in En
| MEDLINE
| ID: mdl-31432377
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Chemical and Drug Induced Liver Injury
/
Glioma
/
Hematologic Diseases
/
Neoplasm Recurrence, Local
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Neurooncol
Year:
2019
Type:
Article
Affiliation country:
United States